These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12654955)

  • 1. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial.
    Gimbel JS; Richards P; Portenoy RK
    Neurology; 2003 Mar; 60(6):927-34. PubMed ID: 12654955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxycodone for neuropathic pain and fibromyalgia in adults.
    Gaskell H; Moore RA; Derry S; Stannard C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.
    Kopecky EA; Vaughn B; Lagasse S; O'Connor M
    Drugs Aging; 2017 Aug; 34(8):603-613. PubMed ID: 28600725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy.
    Watson CP; Moulin D; Watt-Watson J; Gordon A; Eisenhoffer J
    Pain; 2003 Sep; 105(1-2):71-8. PubMed ID: 14499422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.
    Watson CP; Babul N
    Neurology; 1998 Jun; 50(6):1837-41. PubMed ID: 9633737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.
    Kaplan R; Parris WC; Citron ML; Zhukovsky D; Reder RF; Buckley BJ; Kaiko RF
    J Clin Oncol; 1998 Oct; 16(10):3230-7. PubMed ID: 9779696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain.
    Hale ME; Fleischmann R; Salzman R; Wild J; Iwan T; Swanton RE; Kaiko RF; Lacouture PG
    Clin J Pain; 1999 Sep; 15(3):179-83. PubMed ID: 10524470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
    Hale M; Tudor IC; Khanna S; Thipphawong J
    Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study.
    Afilalo M; Etropolski MS; Kuperwasser B; Kelly K; Okamoto A; Van Hove I; Steup A; Lange B; Rauschkolb C; Haeussler J
    Clin Drug Investig; 2010; 30(8):489-505. PubMed ID: 20586515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation.
    Roth SH; Fleischmann RM; Burch FX; Dietz F; Bockow B; Rapoport RJ; Rutstein J; Lacouture PG
    Arch Intern Med; 2000 Mar; 160(6):853-60. PubMed ID: 10737286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.
    Hanna M; O'Brien C; Wilson MC
    Eur J Pain; 2008 Aug; 12(6):804-13. PubMed ID: 18262450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial.
    Caldwell JR; Hale ME; Boyd RE; Hague JM; Iwan T; Shi M; Lacouture PG
    J Rheumatol; 1999 Apr; 26(4):862-9. PubMed ID: 10229408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled-release oxycodone -- a therapeutic option for severe neuropathic pain].
    Wörz R; Frank M; Achenbach U
    MMW Fortschr Med; 2003 Sep; 145(39):45. PubMed ID: 14649073
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.
    Portenoy RK; Farrar JT; Backonja MM; Cleeland CS; Yang K; Friedman M; Colucci SV; Richards P
    Clin J Pain; 2007 May; 23(4):287-99. PubMed ID: 17449988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.